Issue 17, 2022, Issue in Progress

Characterization of a class II ketol-acid reductoisomerase from Mycobacterium tuberculosis

Abstract

Mycobacterium tuberculosis ketol-acid reductoisomerases have been widely studied due to their metabolic importance towards development of drug-resistant bacteria treatment. We here report the biochemical characterization of a new KARI (MtKARI-II) from a Mycobacterium tuberculosis variant with a similar kinetic profile to class I KARIs. Phylogenetic analysis suggested that MtKARI-II is clustered into a class II KARI superfamily.

Graphical abstract: Characterization of a class II ketol-acid reductoisomerase from Mycobacterium tuberculosis

Supplementary files

Article information

Article type
Paper
Submitted
06 Dec 2021
Accepted
30 Mar 2022
First published
06 Apr 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 10540-10544

Characterization of a class II ketol-acid reductoisomerase from Mycobacterium tuberculosis

A. Valera, S. Wang, R. Carr, L. Trembleau and H. Deng, RSC Adv., 2022, 12, 10540 DOI: 10.1039/D1RA08876A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements